运动迟缓型便秘结肠壁内5-羟色胺和P物质的免疫组织化学研究

应用5－羟色胺（5－HT）和P物质（SP）免疫组化方法,对10例运动迟缓型便秘患降结肠、乙状结肠和8例“正常对照”组结肠进行观察,结果发现结肠粘膜下5－HT阳性细胞明显增多,而肠肌间神经丛5－HT增加不明显,SP阳性细胞减少,提示运动迟缓型便秘肠神经系统5－HT和SP免疫反应的异常变化,可能是结肠迟缓性便秘的神经病理基础。     

大鼠肠道内NOS与AChE、VIP阳性神经元的分布关系研究

应用一氧化氮合酶 (NOS)、乙酰胆碱酯酶 (ACh E)组织化学及血管活性肠肽 (VIP)免疫组织化学方法 ,光镜下比较观察大鼠肠道内 NOS、ACh E、VIP阳性神经元的形态学特征。结果显示 ,肠肌间丛 NOS阳性神经元胞体大小不等 ,形态不一 ,NOS、ACh E和 VIP阳性神经元的分布密度为 ACh E>NOS>VIP,在不同的肠段和层次分布密度有差异 ,NOS与 ACh E存在共染。在肌间丛和粘膜下丛 ,少数 VIP与 NOS共染。在粘膜下丛 ,三种阳性神经元的分布密度为 ACh E>VIP>NOS。在肌间丛和粘膜下丛 ,可见 VIP阳性末梢环抱 NOS阳性神经元胞体 ,两者呈终扣样接触。上述结果提示 NOS阳性神经元与 ACh E、 VIP阳性神经元有密切的形态学联系。在消化道功能调节上 ,它们可能起协调作用。     

人胎胃壁内NOS阳性神经元发育的研究

研究用NADPH-d组织化学法对第3个月胎龄至足月人胎胃壁内NOS阳性神经元的分化,迁移和生长发育进行了观察。结果表明：第5个月龄时,肌层神经节处的圆形细胞出现一氧化氮合酶（nitric oxide synthase,NOS)阳性反应。第6个月龄时,NOS阳性细胞分化演变成NOS阳性神经细胞,细胞呈圆形或椭圆形,核大,细胞质极少,由细胞发出短小的6个月龄时,NOS阳性细胞分化演变成NOS阳性神经细胞,细胞呈圆形或椭圆形,核大,细胞质极少,由细胞发出短小的突起,有部分NOS阳性细胞分化演变成梭形的NOS阳性神经细胞,呈条索状排列和粘膜下层延伸,吸的到达粘膜层,在粘膜层形成网状细胞,第7个月龄时,神经元细胞明显增大,细胞质增多,染色加深,在肌层形成神经节,神经节细胞突起投射到整个肌层,第8-10个月龄时,肌层和粘膜下层神经元日趋成熟,细胞质增多,染色强度加深,肌层神经纤维分布密度增加,大多数神经纤维增粗,有的呈弹簧样弯曲,其走向与肌纤维长轴平行。结果提示;人胎胃壁内NOS阳性神经元来源于胚胎早期肌层神经节处的圆形细胞,通过分化,生长发育形成成熟的NOS阳性神经元。     

功能性便秘的生物反馈治疗及疗效随访

目的:观察生物反馈治疗功能性便秘的疗效.方法:对患者进行生物反馈治疗采用随访形式对治疗前后作对比分析.结果:治愈11例,显效27例,有效24例,无效9例,总有效率为87.3%.结论:生物反馈治疗各种类型的功能性便秘均有一定疗效.94.1%的患者认为便秘对个人生活产生了不同程度的负面影响,80.4%的功能性便秘患者远期疗效(半年以上)显著.31.4%患者认为便秘发生与饮食因素关系最大,且大多数患者认为便秘可以治愈.     

不同能量需求的棕色田鼠胃肠道一氧化氮合酶和血管活性肠肽的分布

为研究在能量需求变化的情况下生理功能调节在消化道适应性变化中的地位,并探讨生理调节与消化道形态结构适应性变化的关系,采用NADPH-黄递酶（NDP）组织化学法、VIP免疫组织化学法和整装铺片技术对哺乳和非哺乳雌性棕色田鼠及雄性棕色田鼠胃肠道管壁肌间神经丛和黏膜下神经丛一氧化氮合酶（Nitricoxidesynthase,NOS）和血管活性肠肽（Vasoactive intestinal peptide,VIP）阳性神经元的分布进行观察。结果显示：哺乳和非哺乳雌性棕色田鼠及雄性棕色田鼠NOs阳性神经元分布于肌间神经丛,VIP分布于黏膜下神经丛,未观察到共染现象。NOS和VIP阳性神经元在哺乳雌性棕色田鼠胃及小肠前段的肌间神经丛和黏膜下神经丛的分布显著高于非哺乳雌鼠和雄鼠,而在回肠、盲肠和结肠差异不显著。由此说明,不同繁殖状态下,能量需求的不同促使消化道发生适应性变化,首先是生理功能及其调节机制的变化。同时提示消化道适应策略与消化道各段生理功能及能量胁迫程度有关[动物学报51（5）：830—839,2005]。     

甘肃鼢鼠胃肠道肌间神经丛一氧化氮合酶阳性神经元的分布

用NADPH-黄递酶组织化学法及整装铺片技术,对甘肃鼢鼠(Myospalax cansus)胃肠道肌间神经丛NOS阳性神经元的分布进行研究.结果显示,甘肃鼢鼠胃肠道肌间神经丛NOS阳性神经元分布广泛,形态多样,神经元大小不同,阳性神经节与阳性神经纤维束形成网络;胃肠道不同部位NOS阳性神经元密度有差异,结肠最高,直肠次之.从十二指肠至回肠段,NOS阳性神经元密度整体呈上升趋势;胃与空肠、十二指肠与盲肠间NOS阳性神经元密度无显著差异,其他各段之间差异显著.甘肃鼢鼠胃肠道肌间神经丛NOS阳性神经元分布与其他已研究动物的分布模式基本一致.     

双歧杆菌四联活菌片联合莫沙必利片对功能性便秘患者肠神经递质和结肠传输功能的影响

目的 探讨双歧杆菌四联活菌片联合莫沙必利片对功能性便秘(FC)患者肠神经递质和结肠传输功能的影响。 方法 选取我院门诊治疗的FC患者104例,随机分为观察组(n=52例)和对照组(n=52例)。两组患者均给予饮食调整、养成良好的生活方式和加强排便功能锻炼等基础治疗。对照组患者给予莫沙必利片5 mg/次,3次/d,饭前30 min口服,连用12周。观察组患者在对照组基础上加用双歧杆菌四联活菌片1.5 g/次,3次/d,餐后30 min服用,连用12周。观察两组患者治疗前后血清一氧化氮(NO)、血管活性肠肽(VIP)和生长抑素(SS)水平及Wexner便秘症状评分、全结肠通过时间(TCTT)的变化,并比较其临床效果。 结果 治疗12周后,两组患者血清NO, VIP和SS水平及Wexner便秘症状评分、TCTT时间较治疗前明显下降(均P2 =4.31,P结论 双歧杆菌四联活菌片与莫沙必利片联合治疗FC患者的效果较肯定,能更显著地降低血清肠神经递质NO、VIP和SS水平,提高患者结肠传输功能。     

捕食应激过程中大鼠脑边缘系统一氧化氮合酶神经元的变化

探讨应激状态下大鼠脑边缘系统内一氧化氮合酶 (Nitricoxidesynthase,NOS )阳性神经元的变化及这种变化与脑神经元损伤发生的关系。采用捕食应激动物模型 ,将 80只雄性SD大鼠随机分为 3组 :对照组 (n =2 0 )、单纯捕食应激组 (n =30 )、加强捕食应激组 (n =30 )。采用还原型尼克酰胺腺嘌呤二核苷酸黄递酶(NADPH d)组织化学方法 ,研究应激后 1、 3、 6、 12、 2 1、 30dNOS阳性神经元的分布规律。结果表明 :对照组NOS活性平稳 ,但应激后NOS活性变化明显。与对照组比较 ,应激 1- 3d ,单纯应激组和加强应激组NOS阳性神经元数目在皮质、纹状体、海马、下丘脑等部位增多 ,即NOS活性升高 ;第 4 - 12d ,NOS活性进一步升高 ,除皮质外与对照组相比具显著性差异 (P <0 0 1) ;其中 ,应激单纯组和加强组海马和下丘脑室旁核分别在第 6d、第 12dNOS活性最高。从第 13d起NOS阳性神经元的活性开始逐渐降低 ;到第 30dNOS活性下降明显 ,但其活性仍高于对照组 (P <0 0 5 )。对于同一时间点而言 ,与对照组相比 ,加强应激组的NOS活性变化大于相应的单纯应激组。结果提示 :NOS活性程度与心理应激程度密切相关 ;应激过程中大鼠脑边缘系统过量增多的NO产生的神经毒性可能是应激导致大鼠脑边缘系统神经元受损的原因之一     

中缝背核微量注射L-N-硝基精氨酸甲酯抑制大鼠乙状结肠痛

用Fos免疫组织化学、烟酰胺腺嘌呤二核苷酸磷酸黄递酶(nicotinamide adenine dinucleotide phosphate—di—aphorase,NADPH-d)组织化学及微量注射技术,观察大鼠乙状结肠注射甲醛(5％)诱发的大鼠乙状结肠炎性痛过程中中缝背核一氧化氮合酶(nitric oxide synthase,NOS)神经元的变化,同时观察中缝背核微量注射L-N-硝基精氨酸甲酯(LNAME)对乙状结肠痛的调控作用。结果表明,(1)乙状结肠注射甲醛后,大鼠出现明显的内脏痛反应,中缝背核NOS神经元表达明显增多,中缝背核内出现大量Fos蛋白,在整个中缝背核内均有分布,并且出现Fos／NOS双标神经元,约占中缝背核NOS神经元总数的8％,与生理盐水对照组相比差异有显著性;(2)中缝背核注射L-NAME后,可以明显减少乙状结肠炎性痛大鼠的疼痛学评分及脊髓相应节段Fos蛋白。上述结果提示,中缝背核NOS神经元参与调控大鼠乙状结肠痛,NO在中缝背核促进内脏伤害性信息的传递。     

5-羟色胺和一氧化氮合酶在大鼠中脑导水管周围灰质 和中缝核簇神经元内的共存

实验采用 NADPH组织化学和 5 - HT免疫组织化学双重显色方法研究了 5 - HT和一氧化氮合酶在大鼠中脑导水管周围灰质 (PAG)和中缝核簇神经元的分布特征及共存情况。结果表明 ;(1 )在 PAG腹外侧区中观察到大量的 NOS阳性神经元和 5 - HT样免疫阳性神经元 ,但是 NOS/ 5 - HT双标神经元较少 ,仅占该区 5 - HT样免疫阳性神经元 2 0 .1 % ,并且主要分布在该区的内侧部 ;在 PAG的背外侧区中观察到密集的 NOS阳性神经元 ,但是几乎未见 5 - HT免疫阳性神经元分布。(2 )在中缝核簇的大多数亚核内均可观察到大量的 NOS神经元和 5 - HT免疫阳性神经元。在中缝背核的内侧部、中缝背核的尾侧部、中缝正中核、尾侧线形核、中缝大核和中缝隐核内双标神经元分别占所在部位中 5 - HT免疫阳性神经元的 44 .6 %、5 3.4%、 44 .4%、 2 6 .2 %、 2 6 .7%和 2 1 .8%。然而在中缝苍白核内仅偶见少数双标神经元。研究结果表明 ,在 PAG和中缝核簇的一些神经元内 5 - HT可以与 NOS共存 ,提示这两种神经活性物质在功能上可能存在着某种相关性 ,有关这些双标神经元的功能意义尚需进一步研究。     

Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures

Defects in mitochondrial energy metabolism have been implicated in the pathology of several neurodegenerative disorders. In addition, the reactive metabolites generated from the metabolism and oxidation of the neurotransmitter dopamine (DA) are thought to contribute to the damage to neurons of the basal ganglia. We have previously demonstrated that infusions of the metabolic inhibitor malonate into the striata of mice or rats produce degeneration of DA nerve terminals. In the present studies, we demonstrate that an intrastriatal infusion of malonate induces a substantial increase in DA efflux in awake, behaving mice as measured by in vivo microdialysis. Furthermore, pretreatment of mice with tetrabenazine (TBZ) or the TBZ analogue Ro 4-1284 (Ro-4), compounds that reversibly inhibit the vesicular storage of DA, attenuates the malonate-induced DA efflux as well as the damage to DA nerve terminals. Consistent with these findings, the damage to both DA and GABA neurons in mesencephalic cultures by malonate exposure was attenuated by pretreatment with TBZ or Ro-4. Treatment with these compounds did not affect the formation of free radicals or the inhibition of oxidative phosphorylation resulting from malonate exposure alone. Our data suggest that DA plays an important role in the neurotoxicity produced by malonate. These findings provide direct evidence that inhibition of succinate dehydrogenase causes an increase in extracellular DA levels and indicate that bioenergetic defects may contribute to the pathogenesis of chronic neurodegenerative diseases through a mechanism involving DA.     

Scurvy in capybaras bred in captivity in Argentine

In order to determine if the absence of vitamin C in the diet of capybaras (Hydrochoerus hydrochaeris) causes scurvy, a group of seven young individuals were fed food pellets without ascorbic acid, while another group of eight individuals received the same food with 1 g of ascorbic acid per animal per day. Animals in the first group developed signs of scurvy-like gingivitis, breaking of the incisors and death of one animal. Clinical signs appeared between 25 and 104 days from the beginning of the trial in all individuals. Growth rates of individuals deprived of vitamin C was considerably less than those observed in the control group. Deficiency of ascorbic acid had a severe effect on reproduction of another population of captive capybaras. We found that the decrease in ascorbic acid content in the diet affected pregnancy, especially during the first stages. The results obtained suggest that it is necessary to supply a suitable quantity of vitamin C in the diet of this species in captivity.     

Changes in lactate dehydrogenase activity in chicken tissues in hyperthyreosis in ontogenesis

The lactate dehydrogenase activity in reactions of lactate oxidation and synthesis was studied in subfractions of the chicken brain, heart and liver at the embryonal, early postembryonal and adult stages of development after thyroxine administration. It has been shown that during embryogenesis thyroxine predominantly enhanced the rate of lactate oxidation in the mitochondrial tissues. A marked increase in the lactate synthesis was found in cytoplasm of the adult chicken tissues. Specificity of enzyme activity alterations was detected in the chicken brain during ontogenesis after thyroxine administration.     

SSTR5 ablation in islet results in alterations in glucose homeostasis in mice

Somatostatin (SST) peptide is a potent inhibitor of insulin secretion and its effect is mediated via somatostatin receptor 5 (SSTR5) in the endocrine pancreas. To investigate the consequences of gene ablation of SSTR5 in the mouse pancreas, we have generated a mouse model in which the SSTR5 gene was specifically knocked down in the pancreatic beta cells (betaSSTR5Kd) using the Cre-lox system. Immunohistochemistry analysis showed that SSTR5 gene expression was absent in beta cells at three months of age. At the time of gene ablation, betaSSTR5Kd mice demonstrated glucose intolerance with lack of insulin response and significantly reduced serum insulin levels. Insulin tolerance test demonstrated a significant increase of insulin clearance in vivo at the same age. In vitro studies demonstrated an absence of response to SST-28 stimulation in the betaSSTR5Kd mouse islet, which was associated with a significantly reduced SST expression level in betaSSTR5Kd mice pancreata. In addition, betaSSTR5Kd mice had significantly reduced serum glucose levels and increased serum insulin levels at 12 months of age. Glucose tolerance test at an older age also indicated a persistently higher insulin level in betaSSTR5Kd mice. Further studies of betaSSTR5Kd mice had revealed elevated serum C-peptide levels at both 3 and 12 months of age, suggesting that these mice are capable of producing and releasing insulin to the periphery. These results support the hypothesis that SSTR5 plays a pivotal role in the regulation of insulin secretion in the mouse pancreas.